Autopsy report · NCT02679092

Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

“Funding changes.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Stanford University

Sponsor type

University, hospital or other

Conditions

Legally Induced Abortion Without Mention of Complication

Interventions

Misoprostol; Mifepristone; Hygroscopic cervical dilators

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Sex Differences in Neurobehavioral Response to THC
  “Funding status change.” (86% match in meaning)
• Decision Making in Video Games
  “Funding Goals changed” (80% match in meaning)
• A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer
  “No more funding” (76% match in meaning)
• Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis
  “Funding.” (74% match in meaning)
• PAC-1 for Treatment of Refractory, Metastatic Kidney Cancer
  “funding issues” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.